120 related articles for article (PubMed ID: 24046947)
1. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
[TBL] [Abstract][Full Text] [Related]
2. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
[TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stromal cells can uptake and release ciprofloxacin, acquiring in vitro anti-bacterial activity.
Sisto F; Bonomi A; Cavicchini L; Coccè V; Scaltrito MM; Bondiolotti G; Alessandri G; Parati E; Pessina A
Cytotherapy; 2014 Feb; 16(2):181-90. PubMed ID: 24438899
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
[TBL] [Abstract][Full Text] [Related]
8. Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
Scioli MG; Artuso S; D'Angelo C; Porru M; D'Amico F; Bielli A; Gentile P; Cervelli V; Leonetti C; Orlandi A
PLoS One; 2018; 13(9):e0203426. PubMed ID: 30192811
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.
Brini AT; Coccè V; Ferreira LM; Giannasi C; Cossellu G; Giannì AB; Angiero F; Bonomi A; Pascucci L; Falchetti ML; Ciusani E; Bondiolotti G; Sisto F; Alessandri G; Pessina A; Farronato G
Expert Opin Drug Deliv; 2016 Jun; 13(6):789-98. PubMed ID: 26986001
[TBL] [Abstract][Full Text] [Related]
10. Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines.
Bonomi A; Ghezzi E; Pascucci L; Aralla M; Ceserani V; Pettinari L; Coccè V; Guercio A; Alessandri G; Parati E; Brini AT; Zeira O; Pessina A
Vet J; 2017 May; 223():41-47. PubMed ID: 28671070
[TBL] [Abstract][Full Text] [Related]
11. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.
Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O
Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
[TBL] [Abstract][Full Text] [Related]
14. Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.
Bonomi A; Lisini D; Navone SE; Frigerio S; Dossena M; Ciusani E; Rampini P; Marfia G; Coccè V; Cavicchini L; Sisto F; Parati E; Mantegazza R; Rimoldi M; Rizzetto M; Alessandri G; Pessina A
Cytotherapy; 2015 Mar; 17(3):310-9. PubMed ID: 25457277
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.
Pessina A; Coccè V; Pascucci L; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Crovace A; Falchetti ML; Zicari S; Caruso A; Navone S; Marfia G; Benetti A; Ceccarelli P; Parati E; Alessandri G
Br J Haematol; 2013 Mar; 160(6):766-78. PubMed ID: 23293837
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells uptake and release paclitaxel without reducing its anticancer activity.
Mariotti M; Colognato R; Rimoldi M; Rizzetto M; Sisto F; Cocce V; Bonomi A; Parati E; Alessandri G; Bagnati R; Pessina A
Anticancer Agents Med Chem; 2015; 15(3):400-5. PubMed ID: 24942547
[TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
[TBL] [Abstract][Full Text] [Related]
18. Human skin-derived fibroblasts used as a 'Trojan horse' for drug delivery.
Coccè V; Vitale A; Colombo S; Bonomi A; Sisto F; Ciusani E; Alessandri G; Parati E; Brambilla P; Brambilla M; La Porta CA; Pessina A
Clin Exp Dermatol; 2016 Jun; 41(4):417-24. PubMed ID: 26899383
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of different culture media on the myogenic differentiation potential of adipose tissue- or bone marrow-derived human mesenchymal stem cells.
Stern-Straeter J; Bonaterra GA; Juritz S; Birk R; Goessler UR; Bieback K; Bugert P; Schultz J; Hörmann K; Kinscherf R; Faber A
Int J Mol Med; 2014 Jan; 33(1):160-70. PubMed ID: 24220225
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.
Bochev I; Elmadjian G; Kyurkchiev D; Tzvetanov L; Altankova I; Tivchev P; Kyurkchiev S
Cell Biol Int; 2008 Apr; 32(4):384-93. PubMed ID: 18262807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
